ARCHIVES

Study Validates “PEM” Scans As Biopsy Guidance Method

This article is from The Cancer Letter archive.

Vol. 34 No. 4 | April 29, 2011

Download PDF Visit The Full Archive

Related Articles

Appropriators Project 1.2% Increase for NIH, Due to Budget Plan

June 20, 1997

IOM Panel: NCI Clinical Trials Groups At “Breaking Point,” More Funds Needed.

April 16, 2010

CPT-11, Gemcitabine Increase Survival Of Pancreatic Cancer

March 29, 2002

Also in this 8-page issue: Amgen names PhRMA executive Rodger Currie vice president for government affairs.

April 30, 2004

Senate Committee Investigating Pharma’s “Educational Grants.”

January 20, 2006

DCT Board Okays 11 Concept Contract Recompetitions

October 26, 1984